TCV Trust & Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

TCV Trust & Wealth Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,875	Closed	-$12K	–	177
2015 Q1	$12K	Hold	1,875	–	–	﹤0.01%	180
2014 Q4	$12K	Hold	1,875	–	–	﹤0.01%	172
2014 Q3	$19K	Sell	1,875 -1,429	-43%	-$15.3K	﹤0.01%	168
2014 Q2	$37K	Hold	3,304	–	–	0.01%	172
2014 Q1	$40K	Hold	3,304	–	–	0.01%	166
2013 Q4	$42K	Hold	3,304	–	–	0.01%	167
2013 Q3	$55K	Hold	3,304	–	–	0.01%	155
2013 Q2	$50K	Buy	+3,304	New	+$50.2K	0.01%	152

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $677M AUM 57.21% 1-Year Est. Return

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return